In summary, it is reasonable to conclude that SNX29 gene expression may be relevant to a variety of tumorigenesis factors, the tumor microenvironment, and drug sensitivity, providing new ideas for the development of new targets for the diagnosis, prognostic assessment, and treatment of various cancers. Here, SNX29 is linked to neoplasm.